new glp-1 weight loss oral drug delivers up to 12% in 36 weeks FDA approves Foundayo, an oral

This incretin effect only occurs when foods containing glucose (e.g., starches and carbohydrates) enter the GI tract and does not happen with intravenous glucose administration

21 Tennessee Medicaid approved coverage effective January 1, 2026

Severe post-gastric bypass hypoglycemia in pregnancy

Conclusions In conclusion, GLP-1-RAs present a safe, effective and well-tolerated treatment option for achieving significant weight loss in pwIIH, leading to headache improvement after six months as well

On average, breastfeeding mothers need about 2,000 calories per day plus an additional ~250 calories for milk production sometimes more depending on body size and milk output

Hypoglycaemia (low blood sugar levels) GLP-1 RAs are glucose-dependent stimulators of insulin, meaning they shouldnt cause dangerous hypoglycemia on their own in a healthy person (unlike taking insulin)